Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of the National Cancer Institute

• Publication date

  2000-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01893697-200119020-00017PMID 10699071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction

  2006cited by this paper
• c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients

  2004cited by this paper
• Recent advances in breast cancer biology

  2001cited by this paper
• Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer.

  2000cited by this paper
• Urinary excretion of isoflavonoids and the risk of breast cancer.

  1999cited by this paper
• Molecular epidemiology of breast cancer.

  1998cited by this paper
• Recent advances in breast cancer biology

  1998cited by this paper
• ERBB2 oncogene in human breast cancer and its clinical significance.

  1998cited by this paper
• Molecular epidemiology of breast cancer.

  1997cited by this paper
• Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.

  1994cited by this paper
• The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies.

  1994cited by this paper
• The biology of erbB-2/neu/HER-2 and its role in cancer.

  1994cited by this paper
• neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer.

  1993cited by this paper
• Absence of Activating Mutations in the Transmembrane Domain of the c‐erbB‐2 Proto‐oncogene in Human Lung Cancer

  1992cited by this paper
• Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

  1992cited by this paper
• G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene.

  1991influential reference
• Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer.

  1990cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• A point mutation in the neu oncogene mimics ligand induction of receptor aggregation

  1989cited by this paper
• Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene.

  1989cited by this paper
• Oncogenic activation of the neu‐encoded receptor protein by point mutation and deletion.

  1988cited by this paper
• Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.

  1988cited by this paper
• Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene

  1988cited by this paper
• erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

  1987cited by this paper
• The neu oncogene encodes an epidermal growth factor receptor-related protein

  1986cited by this paper
• The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity.

  1986cited by this paper
• Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

  1986cited by this paper
• Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line

  1986cited by this paper
• Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor

  1986cited by this paper
• Amplification of a novel v-erbB-related gene in a human mammary carcinoma.

  1985cited by this paper
• The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

  1985cited by this paper
• Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

  1985cited by this paper
• The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

  1984cited by this paper

• Effect of HER2 Ile655Val polymorphism on the response to trastuzumab treatment in HER2-positive breast cancer patients

  2025cites this paper
• Exploring the relationship between genetic polymorphisms and cancer in the Bangladeshi population

  2025cites this paper
• Association of ESR1, HER1, and HER2 Polymorphisms with Breast Cancer Risk in the KP Population, A Case-Control Study

  2025cites this paper
• Molecular aspects of BRAF and HER2 in prognosis of periampullary carcinoma.

  2024cites this paper
• Association between HER2 (Ile655Val) polymorphism with risk of breast cancer: An extensive meta-analysis

  2024cites this paper
• Genetic factors in the pathogenesis of cardio-oncology

  2024cites this paper
• Distribution of Her2 Single Nucleotide Polymorphism in Different Geographical location in Sulaimani Province,

  2023cites this paper
• HER2Ile655Val Polymorphism and Risk of Breast Cancer

  2021cites this paper
• Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response

  2021cites this paper
• Association of HER1 and HER2 Gene Variants in the Predisposition of Colorectal Cancer

  2021cites this paper
• Detection of Genetic Polymorphism of HER2 Gene in HER2 Positive Breast Cancer Women in Iraq

  2021cites this paper
• BCL-2 (-938C>A), BAX (-248G>A), and HER2 Ile655Val Polymorphisms and Breast Cancer Risk in Indian Population

  2021cites this paper
• HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.

  2021cites this paper
• Potential Gene Association Studies of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis

  2021cites this paper
• ГЕНЕТИЧЕСКИЙ ПОЛИМОРФИЗМ ЗАБРЮШИННЫХ МИКСОИДНЫХ ЛИПОСАРКОМ

  2020cites this paper
• GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA

  2020cites this paper
• Human Epidermal Growth Factor Receptor-2 gene polymorphism and breast cancer risk in women from the Northeastern region of Brazil

  2020cites this paper
• Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity

  2020cites this paper
• Ile655Val del gen HER2 y su posible valor predictivo en pacientes con síndrome de cáncer de mama y ovario hereditario

  2019cites this paper
• Ile655Val of the HER2 gene and its possible predictive value in patients with hereditary breast and ovarian cancer syndrome

  2019cites this paper
• Nucleic acid amplification-based HER2 molecular detection for breast cancer

  2019cites this paper
• HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility

  2018cites this paper
• Genomic alterations associated with HER2+ breast cancer risk and clinical outcome in response to trastuzumab

  2018cites this paper
• Her2Ile655Val polymorphism and its association with breast cancer risk: an updated meta-analysis of case-control studies

  2018cites this paper
• The Role of the Ste20-like Kinase in Embryonic Development and Neu-induced Mammary Tumorigenesis

  2018cites this paper
• Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis

  2018cites this paper
• genetic association between her 2 and esr 2 polymorphisms and ovarian cancer : a meta-analysis

  2018cites this paper
• The prodigious network of chromosome 17 miRNAs regulating cancer genes that influence the hallmarks of cancer.

  2017cites this paper
• Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy.

  2017cites this paper
• Utilizing Solid Phase Cloning , Surface Display And Epitope Information for Antibody Generation and Characterization

  2017cites this paper
• Mechanisms and Genetic Susceptibility of Chemotherapy-Induced Cardiotoxicity in Patients With Breast Cancer

  2017cites this paper
• Modified allele-specific PCR improves HER2 Ile655Val detection by reducing genotyping errors

  2017cites this paper
• Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population

  2017cites this paper
• Improvement of HER2I655V TARMS-PCR Performance by DNA Quality Analysis

  2017cites this paper
• Helix-helix interactions in membrane domains of bitopic proteins: Specificity and role of lipid environment.

  2017cites this paper
• Improved PCR-RFLP Method For Her-2 Ile655val Breast Cancer Patients Detection

  2016cites this paper
• A PRELIMINARY STUDY OF RISK FACTORS OF BREAST CANCER AND THE USEFULNESS OF BREAST MRI AS AN ADDITION TO MAMMOGRAPHY IN DETECTING BREAST CANCER IN HIGH RISK WOMEN

  2016cites this paper
• Association of HER 2 [ ILe 655 Val ] gene polymorphism and Breast Cancer Risk in Iraqi females Population

  2016cites this paper
• Tumour promoting HER2 splice variant Δ16HER2: Regulation and implication in breast cancer

  2016cites this paper
• Dataset reporting detection of breast cancer-related HER2I655V polymorphism using allele-specific polymerase chain reaction

  2016cites this paper
• Development of Sybr Green I-Based Melting Curve Method for HER2I655V Polymorphism Detection in Breast Cancer

  2016influential citation
• Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study

  2016cites this paper
• Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.

  2016cites this paper
• Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer.

  2016cites this paper
• The Dipole Potential Modifies the Clustering and Ligand Binding Affinity of ErbB Proteins and Their Signaling Efficiency

  2016cites this paper
• ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.

  2016cites this paper
• Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

  2015cites this paper
• Single nucleotide polymorphisms of HER2 related to osteosarcoma susceptibility.

  2015cites this paper
• Analysis of different HER‐2 mutations in breast cancer progression and drug resistance

  2015cites this paper
• Effects of HER2 genetic polymorphisms on its protein expression in breast cancer.

  2015cites this paper
• NOK mediated mitogenic signaling is altered by P203L and V395I mutations.

  2015cites this paper
• BRCA1, BRCA2, HER2 and RAD51 gene polymorphisms in breast cancer patients of Bangladesh

  2015cites this paper
• Detection of novel germline mutations for breast cancer in non‐BRCA1/2 families

  2015cites this paper
• A Study of Her-2/Neu SNP in Breast Cancer Patients

  2015cites this paper
• Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: a meta-analysis

  2015cites this paper
• Systems biology approaches to adverse drug effects: the example of cardio-oncology

  2015cites this paper
• Pharmacogenetics and breast cancer management: current status and perspectives

  2015cites this paper
• Platelet Derived Growth Factor-B and Human Epidermal Growth Factor Receptor-2 Polymorphisms in Gall Bladder Cancer.

  2015cites this paper
• Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.

  2014cites this paper
• Association between the HER 2 Ile 655 Val polymorphism and response to trastuzumab in women with operable primary breast cancer

  2014cites this paper
• 655 Val and 1170 Pro ERBB 2 SNPs in familial breast cancer risk and BRCA 1 alterations

  2014cites this paper
• The genetic variants underlying breast cancer treatment-induced chronic and late toxicities: a systematic review.

  2014cites this paper
• Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.

  2014cites this paper
• HER2 CODON 655 POLYMORPHISM IN HER2 NEGATIVE LUNG CANCER PATIENTS - NEW PROPOSAL FOR ONE OLD DIAGNOSIS

  2014cites this paper
• Allellic HER-2 codon 655 polymorphism and the influence of plasma HER-2 levels in breast cancer Egyptian female patients

  2014cites this paper
• Pharmacogénétique et thérapies ciblées

  2014cites this paper
• Preparation of pro-oncogenic mutant forms V659E and V659Q of the transmembrane domain of receptor protein kinase ErbB2 for structural studies

  2013cites this paper
• HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer

  2013cites this paper
• Preclinical development of transmembrane domains targeting peptides in breast cancer treatment

  2013cites this paper
• Polymorphism and overexpression of HER2/neu among ovarian carcinoma women from Tiruchirapalli, Tamil Nadu, India

  2013cites this paper
• HER1 R497K and HER2 I655V Polymorphisms Are Linked to Development of Breast Cancer

  2013influential citation
• Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS04 trial

  2013cites this paper
• Nous mecanismes de resistència primària al trastuzumab (Herceptin): bases moleculars per a la determinació d'un nou subtipus de càncer de mama (Basal/ErbB2+)

  2013cites this paper
• Pharmacogenetic study of Fc gamma receptor and HER2 genes in breast cancer

  2013cites this paper
• Single nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: A case-control study.

  2012cites this paper
• HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer

  2012cites this paper
• Hereditary Breast Cancer in Sub-Saharan Africa

  2012cites this paper
• Efficient distribution estimation for data with unobserved sub-population identifiers.

  2012cites this paper
• ErbB2, EphrinB1, Src Kinase and PTPN13 Signaling Complex Regulates MAP Kinase Signaling in Human Cancers

  2012cites this paper
• Cancer in the Sudan: an overview of the current status of knowledge on tumor patterns and risk factors.

  2012cites this paper
• Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.

  2011cites this paper
• ERBB 2 ( erythroblastic leukemia viral oncogene homolog 2 , neuro / glioblastoma derived oncogene homolog ( avian ) )

  2011cites this paper
• Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer

  2011cites this paper
• Quantification of EGFR autoantibodies in the amplification phenomenon of HER2 in breast cancer

  2011cites this paper
• HER-2/neu Gene Codon 655 (Ile/Val) Polymorphism in Breast Carcinoma Patients

  2011cites this paper
• Anticorpos monoclonais contra receptor HER2:produção, caracterização e avaliação para uso em testes diagnósticos de tumores de mama humano e canino

  2011cites this paper
• ERBB2 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian))

  2011cites this paper
• Ile/Ile homozygosity at codon 655 of HER2 in schwannoma.

  2011cites this paper
• HER2 Codon 655 G-Allele Is Associated With Reductions in Plasma High-Density Lipoprotein Levels in Breast Cancer Patients Treated With Tamoxifen

  2011cites this paper
• The EGFR R521K polymorphism influences the risk to develop colorectal cancer

  2010cites this paper
• HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma.

  2010cites this paper
• Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women

  2010cites this paper
• HER2 Polymorphisms and Breast Cancer in Tunisian Women

  2010influential citation
• HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies

  2010cites this paper
• Functional analysis of mutant receptor tyrosine kinases involved in cancer pathogenesis

  2010cites this paper
• Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.

  2010cites this paper
• Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments

  2010cites this paper
• P53 Codon 72 and HER2 Codon 655 Polymorphisms in Turkish Breast Cancer Patients

  2010influential citation
• Significance of Serum Tumor Necrosis Factor-Alpha and its Combination with Her-2 Codon 655 Polymorphism in the Diagnosis and Prognosis of Breast Cancer

  2010influential citation
• Transmembrane helix-helix interactions involved in ErbB receptor signaling

  2010cites this paper